X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/24/2868755/0/en/Cue-Biopharma-to-Present-at-the-2024-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/04/08/2859563/0/en/Cue-Biopharma-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Updated-Business-Highlights.html
https://www.globenewswire.com/news-release/2024/04/02/2855889/0/en/Cue-Biopharma-to-Host-Business-Update-Call-and-Webcast.html
https://www.globenewswire.com//news-release/2024/02/29/2838129/0/en/Cue-Biopharma-s-Lead-Clinical-Asset-CUE-101-to-be-Featured-at-the-2024-Multi-disciplinary-Head-and-Neck-Cancers-Symposium.html
https://www.globenewswire.com//news-release/2024/02/06/2824253/0/en/Cue-Biopharma-to-Present-Corporate-Update-at-the-Oppenheimer-34th-Annual-Healthcare-Life-Sciences-Conference.html
https://www.globenewswire.com//news-release/2023/11/22/2784752/0/en/Cue-Biopharma-to-Present-at-the-JMP-Securities-Hematology-and-Oncology-Summit.html
https://www.globenewswire.com//news-release/2023/11/07/2775018/0/en/Cue-Biopharma-to-Present-at-Three-Upcoming-Investor-Healthcare-Conferences-in-November.html
https://www.globenewswire.com//news-release/2023/11/03/2773318/0/en/Cue-Biopharma-Presents-New-Positive-Data-from-Phase-1-Trials-of-CUE-101-in-Head-and-Neck-Cancer-and-CUE-102-in-Wilms-Tumor-1-Positive-Cancers-at-SITC-2023.html
https://www.globenewswire.com//news-release/2023/11/02/2772238/0/en/Cue-Biopharma-to-Host-Business-Update-Call-and-Webcast.html
https://www.globenewswire.com//news-release/2023/09/27/2750471/0/en/Cue-Biopharma-Announces-Upcoming-Scientific-Presentations-at-the-Society-for-Immunotherapy-of-Cancer-s-SITC-38th-Annual-Meeting.html
Market Place
Share 
